UB2-33461-37599
1 vaccination
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 172 / PA
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-23
Dose 1 — Moderna
-
2021-03-24
Registered in v-safe
-
2021-03-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, NauseaAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Itching · DiarrheaAdult check-in
- 2021-03-26
- 2021-03-28
- 2021-04-01
-
2021-04-06
Survey response — day 14, dose 1MedDRA: Headache, Myalgia, Paranasal sinus hypersecretion, Sinus disorder — Feeling: FairFree text: Muscle aches, headache, sinus drainageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2022-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Moderna |
Free text
Release 7 — day 14, dose 1
Symptoms: Muscle aches, headache, sinus drainage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Paranasal sinus hypersecretion | ✓ | · | ✓ |
| SD | Sinus disorder | ○ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release